tetracyclines, chloramphenicol and fluoroquinolones has remained relatively uncommon in H. influenzae in North America. 3, 7, 8 Until recently 3 Canadian data describing rates oflactamase production and antibiotic susceptibilities for M. catarrhalis were not available. Recently published data from the SENTRY antimicrobial surveillance programme showed that 93.0% (120/129) of M. catarrhalis isolates collected by seven Canadian centres in 1997 were -lactamase positive. 3 The two most recent North American studies reported similar rates of -lactamase production (92.0, 95.3%) in M. catarrhalis isolates. 3, 9 At present, resistance to antibiotics other than ampicillin has not emerged as a significant concern with M. catarrhalis. 3 The purpose of the present study was to determine the prevalence of -lactamase production and antibiotic resistance in respiratory tract isolates of H. influenzae and M. catarrhalis recently collected in major population centres across Canada.
Materials and methods

Isolate collection
Between September 1997 and November 1998, 18 Canadian hospital laboratories (Table I) collected lower respiratory tract isolates of H. influenzae (n ϭ 100) and M. catarrhalis (n ϭ 50). Isolates must have been deemed clinically significant by a site's current protocols to be accepted into the study. Only one specimen was considered per patient. All isolates were sent to the co-ordinating laboratory, the Health Sciences Centre (Winnipeg, Manitoba, Canada), on Amies charcoal swabs. The co-ordinating laboratory confirmed the identity of each isolate of H. influenzae by colonial morphology, Gram stain characteristics and X & V factor requirements. Similarly, colonial morphology and Gram stain, as well as oxidase and DNase production were used by the co-ordinating laboratory to confirm the identity of each isolate of M. catarrhalis. Production of -lactamase was assessed by use of the Cefinase disc test (Becton Dickinson Microbiology Systems, Cockeysville, MD, USA). In total, 1352 H. influenzae and 428 M. catarrhalis isolates were available for antibiotic susceptibility testing. Each isolate was stocked in skim milk and stored at -80°C in preparation for antibiotic susceptibility testing by the co-ordinating laboratory.
Antibiotic susceptibility testing
The NCCLS M7-A4 microbroth dilution method 10 10 Isolates were sub-cultured twice on to blood or chocolate agar from -80°C skim milk stocks before MIC testing. Panels were inoculated with bacteria to achieve a final concentration of approximately Antibiotic susceptibilities of the 1352 isolates of H. influenzae are presented in Table II . Isolates were stratified by the presence or absence of -lactamase production and MICs are presented as antibiotic concentrations inhibiting 50 and 90% of isolates and MIC ranges (Table II) . NCCLS interpretative breakpoints 11 were used to divide isolates into per cent susceptible and per cent resistant groups (Table  II) . The ampicillin resistance rate (24.0%) in H. influenzae (Table II) correlated with the -lactamase-positive rate (24.0%) ( Table I ). -Lactamase-positive ampicillin-susceptible isolates of H. influenzae were not identified (Table II) Among the cephalosporins tested cefaclor and loracarbef were the least active against H. influenzae with overall resistance rates of 4.2 and 6.1%, respectively (Table II) . Cefuroxime, cefixime, cefprozil and cefotaxime resistance rates for H. influenzae were lower than those for cefaclor and loracarbef, being 1.7, 1.0, 0.7 and 0.7%, respectively. For loracarbef, cefaclor and cefprozil 14.9, 8.8 and 5.9% of isolates were intermediately resistant.
11 Cefaclor, loracarbef and cefprozil resistance rates were at least two-fold greater among -lactamase-positive H. influenzae compared with -lactamase-negative isolates (Table II) . The activities of cefotaxime, cefuroxime and cefixime appeared unencumbered by the presence of -lactamase. Imipenem was active against all isolates of H. influenzae tested (Table  II) .
Of the H. influenzae isolates tested, 2.7 and 1.7% were resistant to azithromycin and clarithromycin, respectively (Table II) .
11 As interpretative criteria are not available for erythromycin, only MIC 50 and MIC 90 information is presented in Table II . Tetracycline and chloramphenicol resistance rates were 1.9 and 0.2%, respectively. Resistance rates for the fluoroquinolones were also low and ranged from 0 to 0.3% (Table II) . In total, four isolates of H. influenzae with ciprofloxacin MICs of 2 mg/L or greater were identified. Elevated MICs of the other fluoroquinolones tested were also demonstrated for all four isolates. One of the four ciprofloxacin-resistant isolates was also resistant to levofloxacin, grepafloxacin and trovafloxacin 11 and demonstrated a moxifloxacin MIC of 2 mg/L. -Lactamase status did not appear to affect significantly the activity of macrolides, amoxycillin/clavulanate, cefuroxime, tetracycline, ciprofloxacin, levofloxacin, grepafloxacin, trovafloxacin and moxifloxacin against H. influenzae (Table II) . Trimethoprim/sulphamethoxazole resistance was identified in 13.7% of H. influenzae isolates, with approximately twice as many -lactamase-positive isolates (20.4%) demonstrating trimethoprim/sulphamethoxazole resistance as -lactamase-negative isolates (11.4%) ( Table  II) .
Of the 428 isolates of M. catarrhalis, 403 (94.2%) were -lactamase positive (Table I ). -Lactamase rates ranged from 84.1% in Alberta to 100% in Saskatchewan (Table I ). Regional differences in M. catarrhalis -lactamase production were not apparent ( Table I ). The in vitro activities of antibiotics against M. catarrhalis are given in Table III . The NCCLS currently does not provide MIC interpretative breakpoints for M. catarrhalis. The M. catarrhalis susceptibility testing data presented here were interpreted using Haemophilus spp. breakpoints. 9 Other studies have interpreted M. catarrhalis MICs using NCCLS breakpoints for non-fastidious bacteria that grow well on unsupplemented Mueller-Hinton medium. 3 The ampicillin resistance rate, using Haemophilus spp. breakpoints, 11 was 49.5% with 30.6% of M. catarrhalis isolates susceptible to ampicillin (Table III) . Isolates resistant to amoxycillin/ clavulanate, cefotaxime, cefprozil, azithromycin, clarithromycin, ciprofloxacin, levofloxacin, grepafloxacin, trovafloxacin and chloramphenicol were not identified (Table  III) . Resistance rates were less than 1% for cefuroxime, cefaclor, loracarbef, cefixime and tetracycline (Table III) . Trimethoprim/sulphamethoxazole resistance was detected in 1.6% of M. catarrhalis isolates (Table III) .
Discussion
Out-patient respiratory tract infections are commonly treated with empirical antibiotic therapy. The efficacy of 1997, 1992-1993, 1991 and 1985-1987 , respectively. In our study, 24.0% of H. influenzae isolates collected during 1997-1998 produced -lactamase, a result similar to those reported from isolates collected in 1992-1993 and 1991 4, 5 but considerably lower than the rate reported by the SENTRY surveillance programme. 3 Attributing significance to the differences between the -lactamase-positive rates determined regionally and nationally in the present study and those reported previously [3] [4] [5] is difficult because of anomalies in sample size, collection periods, participating centres, restructuring of laboratory services within certain cities and provinces, and patient demographics. If the results of the present study are considered in the absence of the SENTRY surveillance programme, 3 the data suggest that the prevalence of -lactamase production in Canada has levelled off between 1990 and 1997-1998 at approximately 24.0-28.4%. Doern et al. arrived at a similar conclusion concerning -lactamase rates in North America in general. 3 The most notable difference between the present investigation (18 centres, n ϭ 1352) and the recent SENTRY surveillance programme study (seven centres, n ϭ 240) 3 is sample size. Ampicillin-resistant -lactamase-negative isolates and amoxycillin/clavulanate-resistant -lactamase-positive isolates were uncommon, with rates of 0.1 and 0.3%, respectively, and considerably lower than previously reported in the USA. 7 In the present study 13.7, 6.1 and 4.2% of H. influenzae isolates were resistant to trimethoprim/sulphamethoxazole, loracarbef and cefaclor, respectively (Table II) . The SENTRY surveillance programme also determined elevated trimethoprim/sulphamethoxazole and cefaclor resistance rates of 16.2 and 12.8%, respectively, for 240 isolates of H. influenzae from seven centres in Canada in 1997. 3 Trimethoprim/sulphamethoxazole, loracarbef and cefaclor resistance rates in Canada have increased from levels in 1992-1993, when H. influenzae isolates were reported to be susceptible to these antibiotics at rates of 96.8-99.3, 97.9-100 and 93.7-94.7%, respectively. 4 Resistance rates were higher to trimethoprim/sulphamethoxazole, loracarbef, cefaclor and cefprozil in -lactamase-positive than in -lactamase-negative isolates (Table II) . Of the -lactams tested, cefotaxime and cefixime were the most activelactams against both -lactamase-positive and -lactamasenegative isolates of H. influenzae. However, the clinical implications of in vitro resistance to oral antibiotics, specifically cephalosporins, used to treat localized respiratory tract infections arising from H. influenzae has been questioned and remains to be fully elucidated. [12] [13] [14] The rate of -lactamase production among isolates of M. catarrhalis was similar to that reported previously by others. 4, 5 Ampicillin resistance, using Haemophilus spp. breakpoints 11 , was 49.5% with 30.6% of M. catarrhalis isolates susceptible to ampicillin (Table III) . Applying the ampicillin-susceptible breakpoint for non-fastidious bacteria that grow well on unsupplemented Mueller-Hinton medium (р8 mg/L), 3 ,11 all isolates of M. catarrhalis would have been categorized as ampicillin susceptible. -Lactamase-positive M. catarrhalis harbour BRO -lactamases (BRO-1, BRO-2, BRO-3) and have been demonstrated to hydrolyse penicillin, ampicillin and amoxycillin. 9 For 106 (26.3%) of the 403 -lactamase-positive isolates, the ampicillin MICs were р1 mg/L. It is likely that these isolates produced the BRO-2 enzyme, which is known to be associated with low ampicillin MICs as a result of modest amounts of enzyme produced and low substrate affinity. 15, 16 A relationship between the production of BRO -lactamases by M. catarrhalis and clinical failures in patients treated with -lactams has not been determined. 9 In conclusion, 24.0% of H. influenzae and 94.2% of M. catarrhalis isolates from across Canada in 1997-1998 produced -lactamase. -Lactamase production correlated with ampicillin resistance in isolates of H. influenzae but not M. catarrhalis principally because of the differentlactamase enzymes present in each species. H. influenzae demonstrated appreciable resistance to ampicillin (24.0% of isolates), trimethoprim/sulphamethoxazole (13.7% of isolates), loracarbef (6.1% of isolates) and cefaclor (4.2% of isolates). Isolates of M. catarrhalis were widely susceptible to all antibiotics tested other than ampicillin.
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